Growth Metrics

Integra Lifesciences Holdings (IART) Total Debt Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 157.11%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -12.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 5.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -2.48%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.12%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.70%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 15.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -5.48%
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn 53.26%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 53.26%
Dec 31, 2025 6.45%
Sep 30, 2025 47.14%
Jun 30, 2025 -1.62%
Mar 31, 2025 -1.94%
Dec 31, 2024 101.21%
Sep 30, 2024 35.08%
Jun 30, 2024 52.82%
Mar 31, 2024 54.77%
Dec 31, 2023 7.04%
Sep 30, 2023 -1.26%
Jun 30, 2023 -11.58%
Mar 31, 2023 -11.57%
Dec 31, 2022 -11.27%
Sep 30, 2022 0.24%
Jun 30, 2022 0.24%
Mar 31, 2022 -10.12%
Dec 31, 2021 -10.12%
Sep 30, 2021 -10.12%
Jun 30, 2021 -14.76%
Mar 31, 2021 -4.95%
Dec 31, 2020 -22.23%
Sep 30, 2020 -26.72%
Jun 30, 2020 -18.48%
Mar 31, 2020 -17.82%
Dec 31, 2019 0.86%
Sep 30, 2019 -7.50%
Jun 30, 2019 -15.65%
Mar 31, 2019 -32.38%
Dec 31, 2018 -31.65%
Sep 30, 2018 21.74%
Jun 30, 2018 68.34%
Mar 31, 2018 106.82%
Dec 31, 2017 171.27%
Sep 30, 2017 153.27%
Jun 30, 2017 82.38%
Mar 31, 2017 73.90%
Dec 31, 2016 34.01%
Sep 30, 2016 -9.87%
Jun 30, 2016 10.44%
Mar 31, 2016 26.75%
Dec 31, 2015 19.04%
Sep 30, 2015 24.58%
Jun 30, 2015 3.56%
Mar 31, 2015 -4.74%
Dec 31, 2014 123.08%
Sep 30, 2014 20.48%
Jun 30, 2014 23.40%
Mar 31, 2014 31.07%
Dec 31, 2013 -41.94%
Sep 30, 2013 6.21%
Jun 30, 2013 6.21%
Mar 31, 2013 92.88%
Dec 31, 2012 79.13%
Sep 30, 2012 67.21%
Jun 30, 2012 122.94%
Mar 31, 2012 -19.09%
Dec 31, 2011 -27.58%
Sep 30, 2011 -9.41%
Jun 30, 2011 -34.38%
Dec 31, 2010 4.80%